Pharmafile Logo

Blue Mesa Health

Combating Coronavirus Through Reversing Diabetes

The Diabetes Reversal Company has developed a pioneering programme based on sustainable weight loss, evidence-based lifestyle change and one-to-one clinical support to reduce and reverse the effects of Type 2...

Onyx Health

- PMLiVE

Merck enters agreement with Hanmi for investigational NASH drug

Licensing agreement includes $10m upfront payment

Onyx Health Tackles Diabetes with New Client

Onyx Health have continued to grow as an agency during the COVID-19 downturn, expanding their business into the South East of England by winning a new Surrey based client.

Onyx Health

Covid-19: what could it mean for the diabetic population?

Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it

Wilmington Healthcare

- PMLiVE

Key emerging trends in digital health

Improving healthcare for patients and helping doctors be more efficient

- PMLiVE

Merck, Bayer flesh out vericiguat heart failure data at ACC

Drug reduced rate of cardiovascular deaths and hospitalisations

- PMLiVE

BMS partners with Voluntis to co-develop oncology digital therapeutics

Aims to create a mobile app to help patients self-manage their symptoms

Digital divergence

Combining digital and pharma is proving less easy than previously thought

Digital Nation: How Australia became a digital health pioneer

Australia has adopted digital strategies to transform its healthcare system. We sat down with Rachel de Sain, who shares where, and how she contributed to improving digital health products and...

Blue Latitude Health

- PMLiVE

A snapshot of Congenica

PME talks to CEO David Atkins

- PMLiVE

The digital shift in pharma marketing

Indegene’s surveys in 2016 and 2019 show a spike in digital spend

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links